期刊文献+

TNF抑制剂和非甾体抗炎药治疗强直性脊柱炎疗效分析 被引量:7

Evaluation of the Efficacy of TNF Blockers and NSAIDs in Ankylosing Spondylitis
下载PDF
导出
摘要 评估肿瘤坏死因子(TNF)抑制剂和非甾体抗炎药(NSAIDs)治疗强直性脊柱炎(AS)的疗效。检索并纳入2014年7月前TNF抑制剂或NSAIDs治疗AS且与安慰剂对照的随机对照试验。共纳入17篇研究,其中12篇评估TNF抑制剂,5篇评估NSAIDs。Meta分析结果显示:在"疼痛"和"患者总体评估"方面,治疗效果在TNF抑制剂组和NSAIDs组是中等或者大。在"机体功能"方面,TNF抑制剂组治疗效果是大,NSAIDs组是小。在"急性时相反应物"方面,TNF抑制剂组效应量是中等的,而NSAIDs对"急性时相反应物"无显著影响。在"脊柱活动度"方面,NSAIDs的疗效无统计学意义。不同方面很难比较TNF抑制剂和NSAIDs的疗效,但TNF抑制剂较NSAIDs在改善患者机体功能、降低炎症反应方面更有效。TNF抑制剂是否有改善病情作用及与NSAIDs药物如何联合延缓AS结构破坏,仍需高质量、大样本、长期的临床试验来验证。 To evaluate the efficacy of TNF blockers and anti‐inflammatory agents (NSAIDs) in the treatment of ankylosing spondylitis (AS ) . We perform a meta‐analysis of randomised controlled trials (RCTs ) of TNF blockers and anti‐inflammatory agents (NSAIDs) in patients with ankylosing spondylitis reported up to July ,2014 .Altogether ,17 articles were included in the analysis ,12 selected RCTs evaluating anti‐TNF ,and 5 evaluating NSAIDs RCTs .For the domains pain and patient's global assessment ,the treatment effect was large or medium for both TNF blockers and NSAIDs .For the domain physical function ,the effect of TNF blockers was large and NSAIDs on physical function is medium .For the domain acute‐phase reactants ,the effect of TNF blockers was medium ,whereas NSAIDs had no significant effect on acute‐phase reactants .Finally ,for the domain mobility ,the effect size of NSAIDs was small and not significant .The results suggests that it is difficult to campare the efficacy of TNF blockers and NSAIDs in different domains ,but TNF blockers are more effective in improving physical function and decreasing the inflammatory parameters compared with NSAIDs . More high quality ,large sample ,long‐term clinical trial are required to demonstrate the disease‐modifing effect of TNF blockers and how to combined TNF blockers and NSAIDs in improving structural progression in AS .
出处 《医学与哲学(B)》 2015年第4期37-42,共6页 Medicine & Philosophy(B)
关键词 强直性脊柱炎 肿瘤坏死因子抑制剂 非甾体抗炎药 ankylosing spondylitis TNF blockers NSAIDs
  • 相关文献

参考文献37

  • 1Khan M A. Ankylosing Spondylitis[M]. New York:Oxford University Press, 2009: 1 - 147. 被引量:1
  • 2Dougados M, Hochberg M C. Why is the concept of spondyloar- thropath es mportant?[J]. Best Pract Res Clin Rheumatol, 2002,16 (4) :495-505. 被引量:1
  • 3Zhang S, Li Y,Deng X, et al. Similarities and differences between spondyloarthritis in Asia and other parts of the world[J]. Curr Opin Rheumatol,2011,23(4) :334-338. 被引量:1
  • 4刘海燕,肖丽,郭冬梅,艾群,姜国民.强直性脊柱炎的临床、实验室与放射学关系的探讨[J].大连医科大学学报,2001,23(2):102-104. 被引量:4
  • 5Chen J, Liu C. Methotrexate for ankylosing spondylitis[J]. Cochrane Database Syst Rev,2004(3):CD004524. 被引量:1
  • 6黄烽,李胜光,刘泽星,蔡文展.甲氨蝶呤治疗早期强直性脊柱炎疗效的初步评价[J].中国新药杂志,2001,10(9):689-692. 被引量:18
  • 7Braun J, Zochling J, Baraliakos X, et al. Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloar- thritis and early ankylosing spondylitis: a multicentre randomised con- trolled trial[J]. Ann Rheum Dis,2006,65(9): 1147-1153. 被引量:1
  • 8Zochling J, van der Heijde D, Burgos-Vargas R, et al. ASAS/EU- LAR recommendations for the management of ankylosing spondyli- tis[J]. Ann Rheum Dis,2006,65(4) :442-452. 被引量:1
  • 9Braun J,Van Den Berg R,Barallakos X,et al. 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis[J]. Ann Rheum Dis,2011,70(6):896-904. 被引量:1
  • 10Wanders A, Heijde D,Landewe R,et al. Nonsteroidal antiinflammatory drugs reduce radiographic progression in patients with ankylosing spondylitis: a randomized clinical trial[J]. Arthritis Rheum, 2005,52(6):1756-1765. 被引量:1

二级参考文献17

  • 1曾庆馀 蒋明 等.骨性关节炎.风湿病学[M].北京:科学出版社,1996.1368-1387. 被引量:3
  • 2[1]Khan M.A current perspective on ankylosing spondylitis and related spondyloarthropathies[J].J Ind Rheum Asso,1999,7(1)∶16-22. 被引量:1
  • 3[2]Yu D.Spondyloarthropathies[J].Rheum Dis Clin North Am,1998,24(4)∶663-894. 被引量:1
  • 4[3]Marker-Hermann E,Hohler T.Pathogenesis of HLA-B27 positive arthritis:information from clinical materials[J].Rheum Dis Clin North Am,1998,24(4)∶865-882. 被引量:1
  • 5[4]Ferraz M,Tugwell P,Goldsmith C,et al.Meta-analysis of sulphasalazine in ankylosing spondylitis[J].J Rheumatol,1990,17(11)∶1482-1486. 被引量:1
  • 6[5]Dougados M,van der Linden S,Leirisalo-Repo M,et al.Sulphasalazine in the treatment of ankylosing spondylitis:a randomized, multicentre,double-blind,placebo-controlled study[J].Arthritis Rheum,1995,38(5)∶618-627. 被引量:1
  • 7[6]Sampaio-Burros P,Costallat L,Bertolo M,et al.Methotrexate in the treatment of ankylosing spondylitis[J].Scand J Rheumatol,2000,29(3)∶160-162. 被引量:1
  • 8[7]Creemers M,Franssen M,van der Putte L,et al.Methotrexate in severe ankylosing spondylitis:an open study[J].J Rheumatol,1995,22(6)∶1104-1107. 被引量:1
  • 9[8]Handler R.Favorable results using methotrexate in the treatment of patients with ankylosing spondylitis[J].Arthritis Rheum,1989,32(2)∶234. 被引量:1
  • 10[9]Ferraz M,Silva H,Atra E.Low dose methotrexate with leucovorin rescue in AS[J].J Rheumatol,1991,18(1)∶146-147. 被引量:1

共引文献20

同被引文献80

引证文献7

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部